download table |
2011 | |||||||||||||||||||||||
€ million |
Silicones |
Polymers |
Biosolutions |
Polysilicon |
Siltronic |
Other |
Con- |
Group | |||||||||||||||
| |||||||||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
External sales |
1,580.2 |
901.4 |
138.9 |
1,234.8 |
985.1 |
69.3 |
– |
4,909.7 | |||||||||||||||
Internal sales |
13.6 |
26.7 |
5.6 |
212.9 |
7.0 |
107.6 |
-373.4 |
– | |||||||||||||||
Total sales |
1,593.8 |
928.1 |
144.5 |
1,447.7 |
992.1 |
176.9 |
-373.4 |
4,909.7 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
103.3 |
76.2 |
13.3 |
545.6 |
-56.7 |
-78.9 |
0.4 |
603.2 | ||||||||||||||||
Write-downs and impairments/ |
79.6 |
35.6 |
7.1 |
201.7 |
105.9 |
71.1 |
– |
501.0 | |||||||||||||||
182.9 |
111.8 |
20.4 |
747.3 |
49.2 |
-7.8 |
0.4 |
1,104.2 | ||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
EBIT includes: |
|
|
|
|
|
|
|
| |||||||||||||||
Income from investments in joint ventures and associates |
16.7 |
– |
– |
– |
-24.4 |
– |
– |
-7.7 | |||||||||||||||
Impairment losses |
– |
– |
-0.7 |
-25.9 |
-14.8 |
– |
– |
-41.4 | |||||||||||||||
Additions to property, plant and equipment1 |
87.9 |
30.4 |
8.6 |
566.5 |
93.2 |
141.3 |
– |
927.9 | |||||||||||||||
Additions to financial assets2 |
18.4 |
– |
– |
– |
34.9 |
– |
– |
53.3 | |||||||||||||||
Asset additions |
106.3 |
30.4 |
8.6 |
566.5 |
128.1 |
141.3 |
– |
981.2 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
Assets (Dec. 31) |
1,197.7 |
478.9 |
96.1 |
1,928.7 |
1,190.4 |
1,672.0 |
-326.8 |
6,237.0 | |||||||||||||||
Liabilities (Dec. 31) |
597.9 |
209.1 |
39.8 |
1,796.4 |
317.3 |
965.5 |
-318.7 |
3,607.3 | |||||||||||||||
Net assets (Dec. 31) |
599.8 |
269.8 |
56.3 |
132.3 |
873.1 |
706.5 |
-8.1 |
2,629.7 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
Investments in joint ventures and associates included in net assets (Dec. 31) |
80.0 |
– |
– |
– |
44.5 |
– |
– |
124.5 | |||||||||||||||
Research and development expenses |
-25.4 |
-14.1 |
-6.2 |
-14.5 |
-71.7 |
-42.8 |
1.8 |
-172.9 | |||||||||||||||
Employees (Dec. 31) |
3,956 |
1,412 |
354 |
2,251 |
4,974 |
4,221 |
– |
17,168 | |||||||||||||||
Employees (average) |
3,957 |
1,404 |
357 |
2,054 |
5,002 |
4,160 |
– |
16,934 |
download table |
2010 | |||||||||||||||||||||||
€ million |
Silicones |
Polymers |
Biosolutions |
Polysilicon |
Siltronic |
Other |
Con- |
Group | |||||||||||||||
| |||||||||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
External sales |
1,563.3 |
788.9 |
138.0 |
1,177.5 |
1,018.7 |
62.0 |
– |
4,748.4 | |||||||||||||||
Internal sales |
17.2 |
21.1 |
4.4 |
191.2 |
6.1 |
95.1 |
-335.1 |
– | |||||||||||||||
Total sales |
1,580.5 |
810.0 |
142.4 |
1,368.7 |
1,024.8 |
157.1 |
-335.1 |
4,748.4 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
EBIT |
150.0 |
82.2 |
16.6 |
586.7 |
-3.5 |
-65.5 |
-1.9 |
764.6 | |||||||||||||||
Write-downs and impairments/ |
79.9 |
40.4 |
8.4 |
146.7 |
91.2 |
63.3 |
– |
429.9 | |||||||||||||||
EBITDA |
229.9 |
122.6 |
25.0 |
733.4 |
87.7 |
-2.2 |
-1.9 |
1,194.5 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
EBIT includes: |
|
|
|
|
|
|
|
| |||||||||||||||
Income from investments in joint ventures and associates |
-14.1 |
– |
– |
– |
-24.0 |
0.1 |
– |
-38.0 | |||||||||||||||
Impairment losses |
-7.5 |
-3.5 |
-1.4 |
– |
-0.3 |
– |
– |
-12.7 | |||||||||||||||
Additions to property, plant and equipment1 |
92.1 |
13.1 |
6.5 |
309.9 |
63.8 |
115.4 |
– |
600.8 | |||||||||||||||
Additions to financial assets2 |
0.8 |
– |
– |
– |
11.7 |
0.6 |
– |
13.1 | |||||||||||||||
Asset additions |
92.9 |
13.1 |
6.5 |
309.9 |
75.5 |
116.0 |
– |
613.9 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
Acquisitions |
81.2 |
– |
– |
– |
– |
– |
– |
81.2 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
Assets (Dec. 31) |
1,084.7 |
413.1 |
91.8 |
1,476.6 |
1,237.2 |
1,542.0 |
-344.2 |
5,501.2 | |||||||||||||||
Liabilities (Dec. 31) |
524.5 |
172.9 |
36.9 |
1,391.0 |
293.9 |
976.1 |
-340.9 |
3,054.4 | |||||||||||||||
Net assets (Dec. 31) |
560.2 |
240.2 |
54.9 |
85.6 |
943.3 |
565.9 |
-3.3 |
2,446.8 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
Investments in joint ventures and associates included in net assets (Dec. 31) |
42.7 |
– |
– |
– |
69.0 |
– |
– |
111.7 | |||||||||||||||
Research and development expenses |
-25.3 |
-14.0 |
-3.5 |
-12.8 |
-72.3 |
-39.3 |
2.1 |
-165.1 | |||||||||||||||
Employees (Dec. 31) |
3,892 |
1,377 |
363 |
1,763 |
5,025 |
3,894 |
– |
16,314 | |||||||||||||||
Employees (average) |
3,737 |
1,369 |
354 |
1,715 |
5,024 |
3,834 |
– |
16,033 |